Literature DB >> 6796532

Gut hormone changes after jejunoileal (JIB) or biliopancreatic (BPB) bypass surgery for morbid obesity.

D L Sarson, N Scopinaro, S R Bloom.   

Abstract

The treatment of obesity by intestinal bypass provides a unique model for the investigation of gut hormone release from the functionally deranged bowel. We have examined the postprandial response of eight circulating gut or pancreatic peptide hormones in 16 preoperative obese patients, 20 patients with jejunoileal bypass, 38 patients with biliopancreatic bypass and 13 age and sex-matched controls. Basal and post-meal hormone concentrations were determined by specific radioimmunoassay methods. Reductions of the upper small intestinal hormones, motilin and gastric inhibitory polypeptide were found in both types of surgery. Conversely, the ileal hormones neurotensin and enteroglucagon were elevated following surgery. This pattern is consistent with the known distribution of these hormones. Variations of response due to surgical differences were noted for gastrin and the enteropancreatic axis, which was more markedly disturbed after biliopancreatic bypass. The alterations of hormone release closely reflect the anatomical changes induced by each particular surgical technique.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796532

Source DB:  PubMed          Journal:  Int J Obes


  40 in total

Review 1.  Gut adaptation and the glucagon-like peptides.

Authors:  D J Drucker
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

2.  Metabolic laparoscopic gastric bypass for obese patients with type 2 diabetes.

Authors:  Mário Nora; Marta Guimarães; Rui Almeida; Paulo Martins; Gil Gonçalves; Maria José Freire; Tiago Ferreira; Cláudia Freitas; Mariana P Monteiro
Journal:  Obes Surg       Date:  2011-11       Impact factor: 4.129

3.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Alberto Patriti; Enrico Facchiano; Annibale Donini
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

Review 4.  Morbid obesity and sleeve gastrectomy: how does it work?

Authors:  Joanna Papailiou; Konstantinos Albanopoulos; Konstantinos G Toutouzas; Christos Tsigris; Nikolaos Nikiteas; George Zografos
Journal:  Obes Surg       Date:  2010-10       Impact factor: 4.129

5.  Enteroendocrine cells: neglected players in gastrointestinal disorders?

Authors:  Gordon W Moran; Fiona C Leslie; Scott E Levison; J Worthington; John T McLaughlin
Journal:  Therap Adv Gastroenterol       Date:  2008-07       Impact factor: 4.409

Review 6.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.

Authors:  David E Cummings; Joost Overduin; Karen E Foster-Schubert; Molly J Carlson
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

7.  Time course of adaptive regulatory peptide changes following massive small bowel resection in the dog.

Authors:  T E Adrian; J S Thompson; E M Quigley
Journal:  Dig Dis Sci       Date:  1996-06       Impact factor: 3.199

Review 8.  Surgical treatment of obesity.

Authors:  Nancy Puzziferri; Jeanne Blankenship; Bruce M Wolfe
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 9.  Obesity, gut hormones, and bariatric surgery.

Authors:  Dimitrios J Pournaras; Carel W le Roux
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

10.  Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats.

Authors:  M B Mumphrey; L M Patterson; H Zheng; H-R Berthoud
Journal:  Neurogastroenterol Motil       Date:  2012-10-24       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.